List view / Grid view
Pfizer spokesperson reveals supply chain challenges and late clinical trial results contributed to its COVID-19 vaccine production target for 2020 being halved.
According to a recent article, China has approved a number of home-grown vaccines, offering alternatives to global drugmakers' products.
Dr Stephen Hahn has been voted into the role of FDA commissioner by the US Senate, taking over the role from Ned Sharpless.
China has expanded a pilot drug bulk-buying programme to almost the entire country which is adding pressure on pharma companies.
The government in China has stated that small quantities of generic medicines that are legal in foreign countries will no longer be classed as “fake drugs”.
